Cargando…
Improving Medication‐Related Outcomes in Chronic Liver Disease
Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medicat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603526/ https://www.ncbi.nlm.nih.gov/pubmed/33163829 http://dx.doi.org/10.1002/hep4.1612 |
_version_ | 1783603941945114624 |
---|---|
author | Hayward, Kelly L. Weersink, Rianne A. |
author_facet | Hayward, Kelly L. Weersink, Rianne A. |
author_sort | Hayward, Kelly L. |
collection | PubMed |
description | Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medication‐related problems (MRPs) have been associated with adverse patient outcomes, including hospitalization and mortality. Factors that can contribute to MRPs in people with CLD are variable and often entwined. This narrative literature review discusses key barriers and opportunities to modify risk factors and improve medication‐related outcomes for people with CLD. |
format | Online Article Text |
id | pubmed-7603526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76035262020-11-05 Improving Medication‐Related Outcomes in Chronic Liver Disease Hayward, Kelly L. Weersink, Rianne A. Hepatol Commun Review Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medication‐related problems (MRPs) have been associated with adverse patient outcomes, including hospitalization and mortality. Factors that can contribute to MRPs in people with CLD are variable and often entwined. This narrative literature review discusses key barriers and opportunities to modify risk factors and improve medication‐related outcomes for people with CLD. John Wiley and Sons Inc. 2020-10-10 /pmc/articles/PMC7603526/ /pubmed/33163829 http://dx.doi.org/10.1002/hep4.1612 Text en © 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Hayward, Kelly L. Weersink, Rianne A. Improving Medication‐Related Outcomes in Chronic Liver Disease |
title | Improving Medication‐Related Outcomes in Chronic Liver Disease |
title_full | Improving Medication‐Related Outcomes in Chronic Liver Disease |
title_fullStr | Improving Medication‐Related Outcomes in Chronic Liver Disease |
title_full_unstemmed | Improving Medication‐Related Outcomes in Chronic Liver Disease |
title_short | Improving Medication‐Related Outcomes in Chronic Liver Disease |
title_sort | improving medication‐related outcomes in chronic liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603526/ https://www.ncbi.nlm.nih.gov/pubmed/33163829 http://dx.doi.org/10.1002/hep4.1612 |
work_keys_str_mv | AT haywardkellyl improvingmedicationrelatedoutcomesinchronicliverdisease AT weersinkriannea improvingmedicationrelatedoutcomesinchronicliverdisease |